Masimo Corporation: Business Overview, Financials & Competitive Analysis
Masimo Corporation scores 7/10 on the AskCyborg Cyborg Score (Strong). Essential medical device player with dominant pulse oximetry technology, expanding hospital automation platform, and compelling 2028 targets, though near-term execution and valuation warrant monitoring. Masimo demonstrates solid fundamentals with double-digit market cap (~$7B), consistent revenue growth (9% in 2025), strong institutional ownership, and a market leadership position in pulse oximetry.
What is Masimo Corporation's industry? Masimo Corporation (masimo.com) operates in Medical Devices & Equipment - Patient Monitoring & Hospital Automation. AskCyborg classifies Masimo Corporation under Medical Devices & Equipment - Patient Monitoring & Hospital Automation in its company registry.
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, and patient monitors. Masimo SET pulse oxi...
Cyborg Score thesis
Essential medical device player with dominant pulse oximetry technology, expanding hospital automation platform, and compelling...
Read the full analyst-debate transcript →Get the Latest Masimo Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeMasimo Corporation Overview
Pro stress-test →Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, and patient monitors. Masimo SET pulse oximetry has been shown to outperform other pulse oximetry technologies in over 100 independent studies and is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals. The company combines core patient monitoring with hospital automation and telehealth platforms to drive integrated care delivery solutions.
Strategic Profile
Pro stress-test →In 2025, Masimo achieved a record level of incremental contract value from new customers and expanded hospital agreements with existing customers, positioning the company well for sustained performance in the year ahead. The company has outlined a long-term strategic vision to strengthen its position as a global leader in patient monitoring, expand its innovation pipeline, with updated 2028 financial targets including revenue growth of 7%-10% on a compound annual basis and operating margins approaching 30%.
Competitive Landscape
Pro stress-test →Masimo competes in noninvasive monitoring by offering brain function, hemodynamic, and respiration monitoring solutions through direct sales, distributors, and OEM partnerships to hospitals, emergency services, long-term care, and physician offices. Key competitors include other medical device manufacturers focused on patient monitoring, hospital automation, and care delivery solutions. Masimo's differentiation centers on its proprietary SET pulse oximetry technology and integrated hospital automation platform.
Industry Context
Masimo Corporation operates in Medical Devices & Equipment - Patient Monitoring & Hospital Automation.
Key facts
Founded: 1989 · Headquarters: Irvine, California · Revenue: $1.5B · Market cap: $7.0B